[1]
Sacchi, V. 2008. Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection. Farmeconomia. Health economics and therapeutic pathways. 9, 4 (Jan. 2008), 215–218. DOI:https://doi.org/10.7175/fe.v9i4.238.